Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...

CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE European Patent ...

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Barron’s annual list of unloved stocks ranges from tech giant Alibaba to miner Barrick to auto rental stalwart Hertz Global.

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

Now, Pfizer and BioNTech are joining forces to try to grab a slice of the market. Having already brought their mRNA-based COVID-19 vaccine Comirnaty to market at breakneck speed, Pfizer and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

At the same time as the German ruling class prepares its third bid for world power with war credits of at least €1 trillion, ...

The recent FDA approval of the first COVID-19 vaccine, along with reports indicating a robust GDP growth rate, make the backdrop ...

Mar. 18, 2025 — Livestock agriculture is bearing the cost of extreme weather events. A new study explores how heat stress affects U.S. dairy production, finding that high heat and humidity lead ...